CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan

OBJECTIVE: Loss of caudal-type homeobox transcription factor 2 (CDX2) expression in colorectal cancers (CRCs) has recently been proposed as a promising predictive biomarker for not only prognosis but also response to chemotherapy. However, the relationship between alterations in CDX2 expression duri...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Shigematsu, Yasuyuki, Inamura, Kentaro, Mise, Yoshihiro, Saiura, Akio, Rehnberg, Emil, Yamamoto, Noriko, Ishikawa, Yuichi, Takahashi, Shunji, Kanda, Hiroaki
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2018
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5908305/
https://ncbi.nlm.nih.gov/pubmed/29682204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24842
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller